Livio Garattini,Anna Padula,Nicholas Freemantle
Livio Garattini
Something borrowed, something new: measuring hospital performance in the context of value based health care [0.03%]
借与新：价值医疗框架下的医院绩效评估
Peter Lindgren,Rikard Althin
Peter Lindgren
Yuxi Wang,Giovanni Fattore
Yuxi Wang
The great economic crisis in 2008 has affected the welfare of the population in countries such as Italy. Although there is abundant literature on the impact of the crisis on physical health, very few studies have focused on the causal impli...
Which multi-attribute utility instruments are recommended for use in cost-utility analysis? A review of national health technology assessment (HTA) guidelines [0.03%]
哪些多属性效用测量工具被推荐用于成本效益分析？全国卫生技术评估指南综述
Matthew Kennedy-Martin,Bernhard Slaap,Michael Herdman et al.
Matthew Kennedy-Martin et al.
Background: Several multi-attribute utility instruments (MAUIs) are available from which utilities can be derived for use in cost-utility analysis (CUA). This study provides a review of recommendations from national healt...
An exploration of methods for obtaining 0 = dead anchors for latent scale EQ-5D-Y values [0.03%]
探索获得潜在量表EQ-5D-Y值的0=无效锚点的方法
Koonal K Shah,Juan Manuel Ramos-Goñi,Simone Kreimeier et al.
Koonal K Shah et al.
Objectives: Discrete choice experiments (DCEs) can be used to obtain latent scale values for the EQ-5D-Y, but these require anchoring at 0 = dead to meet the conventions of quality-adjusted life year (QALY) estimation. Th...
Cost-utility analysis of inotuzumab ozogamicin for relapsed or refractory B cell acute lymphoblastic leukemia from the perspective of Taiwan's health care system [0.03%]
从台湾医疗体系的角度分析依沙佐米治疗复发或难治B细胞急性淋巴细胞白血病的成本效用
Tsung-Ying Lee,Hsuan-Ying Chen,Tsai-Yun Chen et al.
Tsung-Ying Lee et al.
Objectives: We conduct a cost-utility analysis of inotuzumab ozogamicin (INO) versus chemotherapy as the standard of care (SOC) for adults with relapsed or refractory B cell acute lymphoblastic leukemia. ...
Friedrich Breyer,Normann Lorenz
Friedrich Breyer
Rahmiye Figen Ceylan,Burhan Ozkan,Esra Mulazimogullari
Rahmiye Figen Ceylan
Like wars and socio-politic shifts, contagious diseases have changed the economics and politics of the world throughout history. In 2020, the world faced COVID-19, a globally effective virus leading to mass losses and socio-economic panic. ...
Meimei Wang,Steffen Flessa
Meimei Wang
The excess economic burden of mental disorders: findings from a cross-sectional prevalence survey in Austria [0.03%]
奥地利横断面流行病学调查中精神障碍的过度经济负担的发现
Agata Łaszewska,Johannes Wancata,Rebecca Jahn et al.
Agata Łaszewska et al.
Information about the scope of mental disorders (MDs), resource use patterns in health and social care sectors and economic cost is crucial for adequate mental healthcare planning. This study provides the first representative estimates abou...